Stock Events

Stock Events

AlphaTON Capital 

$0.34
38
+$0.01+2.85% Today

Statistics

Day High
0.35
Day Low
0.32
52W High
0.4
52W Low
0.22
Volume
130,610,570
Avg. Volume
-
Mkt Cap
1.97M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q4 2025
Next
-0.35
-0.35
-0.34
-0.34
Expected EPS
-0.34
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-13.53MNet Income

Analyst Ratings

2Average Price Target
The highest estimate is 2.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATON.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.67B
CRISPR Therapeutics focuses on gene editing, competing in the innovative biotech therapies space similar to Portage.
Editas Medicine
EDIT
Mkt Cap256.51M
Editas Medicine is also involved in gene editing technology, directly competing with Portage's biotech innovations.
Intellia Therapeutics
NTLA
Mkt Cap1.91B
Intellia Therapeutics is a key player in CRISPR/Cas9 technology, a direct competitor in the genetic medicine field.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.01B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, overlapping with Portage's market.
Alnylam Pharmaceuticals
ALNY
Mkt Cap38.32B
Alnylam Pharmaceuticals works on RNAi therapeutics, competing in the novel biopharmaceuticals space.
Sarepta Therapeutics
SRPT
Mkt Cap1.85B
Sarepta Therapeutics focuses on the discovery and development of RNA-targeted medicine, similar to Portage's approach.
Sangamo Therapeutics
SGMO
Mkt Cap55.93M
Sangamo Therapeutics specializes in genomic medicine, directly competing in the genetic editing and therapy sector.
Beam Therapeutics
BEAM
Mkt Cap2.87B
Beam Therapeutics uses base editing technology, a novel approach in the competitive genetic medicine industry.
Voyager Therapeutics
VYGR
Mkt Cap223.86M
Voyager Therapeutics focuses on severe neurological diseases with gene therapy, competing in the advanced therapy sector.

About

Alpha Compute Corp. is a technology company scaling the Telegram super app, a strategic reserve of digital assets. The firm implements a comprehensive M&A and treasury strategy that combines direct digital assets acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.
Show more...
CEO
ISIN
VGG7185A1369

Listings

XNAS
US
ATON
XNAS
US
ALP
BOATS
BOATS
ATON.BOATS

0 Comments

Share your thoughts

FAQ

What is AlphaTON Capital stock price today?▼
The current price of ATON.BOATS is $0.34 USD — it has increased by +2.85% in the past 24 hours. Watch AlphaTON Capital stock price performance more closely on the chart.
What is AlphaTON Capital stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange AlphaTON Capital stocks are traded under the ticker ATON.BOATS.
What is AlphaTON Capital market cap?▼
Today AlphaTON Capital has the market capitalization of 1.97M
When is the next AlphaTON Capital earnings date?▼
AlphaTON Capital is going to release the next earnings report on July 23, 2026.
What were AlphaTON Capital earnings last quarter?▼
ATON.BOATS earnings for the last quarter are -0.35 USD per share, whereas the estimation was -0.35 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is AlphaTON Capital revenue for the last year?▼
AlphaTON Capital revenue for the last year amounts to 0 USD.
What is AlphaTON Capital net income for the last year?▼
ATON.BOATS net income for the last year is -13.53M USD.
In which sector is AlphaTON Capital located?▼
AlphaTON Capital operates in the Other sector.
When did AlphaTON Capital complete a stock split?▼
AlphaTON Capital has not had any recent stock splits.